Superstring Capital Management LP Portfolio Holdings
Superstring Capital Management LP
- $84.5 Billion
- Q2 2025
Superstring Capital Management LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $84.5 Billion distributed in 36 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cogent Biosciences, Inc. with a value of $6.91B, Verona Pharma PLC with a value of $6.52B, Neurocrine Biosciences Inc with a value of $5.1B, Terns Pharmaceuticals, Inc. with a value of $4.8B, and Ultragenyx Pharmaceutical Inc. with a value of $4.74B.
Examining the 13F form we can see an increase of $408M in the current position value, from $84B to 84.5B.
Superstring Capital Management LP is based out at New York, NY
Below you can find more details about Superstring Capital Management LP portfolio as well as his latest detailed transactions.